Resona Asset Management Co. Ltd. Takes $2.56 Million Position in Henry Schein, Inc. (NASDAQ:HSIC)

Resona Asset Management Co. Ltd. purchased a new position in shares of Henry Schein, Inc. (NASDAQ:HSIC - Free Report) in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor purchased 36,841 shares of the company's stock, valued at approximately $2,556,000.

A number of other large investors also recently bought and sold shares of HSIC. Versant Capital Management Inc raised its position in shares of Henry Schein by 274.6% in the 4th quarter. Versant Capital Management Inc now owns 457 shares of the company's stock worth $32,000 after buying an additional 335 shares during the period. Venturi Wealth Management LLC raised its holdings in shares of Henry Schein by 3,347.1% in the 4th quarter. Venturi Wealth Management LLC now owns 586 shares of the company's stock worth $41,000 after purchasing an additional 569 shares during the period. Quent Capital LLC lifted its stake in shares of Henry Schein by 91.2% in the 4th quarter. Quent Capital LLC now owns 677 shares of the company's stock valued at $47,000 after purchasing an additional 323 shares in the last quarter. Smartleaf Asset Management LLC lifted its stake in shares of Henry Schein by 23.2% in the 4th quarter. Smartleaf Asset Management LLC now owns 759 shares of the company's stock valued at $52,000 after purchasing an additional 143 shares in the last quarter. Finally, City State Bank purchased a new stake in shares of Henry Schein during the 4th quarter worth about $55,000. Hedge funds and other institutional investors own 96.62% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts have weighed in on the stock. StockNews.com raised shares of Henry Schein from a "hold" rating to a "buy" rating in a research report on Wednesday, April 9th. Wells Fargo & Company started coverage on shares of Henry Schein in a report on Friday, February 14th. They set an "equal weight" rating and a $80.00 target price on the stock. UBS Group lowered their price target on Henry Schein from $83.00 to $80.00 and set a "neutral" rating for the company in a report on Wednesday, February 26th. Jefferies Financial Group boosted their price objective on Henry Schein from $77.00 to $80.00 and gave the stock a "hold" rating in a research note on Thursday, January 23rd. Finally, Barrington Research reiterated an "outperform" rating and issued a $90.00 target price on shares of Henry Schein in a research note on Wednesday, February 26th. Five equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has assigned a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average target price of $81.10.

Insiders Place Their Bets

In related news, Director Philip A. Laskawy sold 2,604 shares of the stock in a transaction dated Wednesday, March 19th. The shares were sold at an average price of $71.04, for a total transaction of $184,988.16. Following the sale, the director now owns 24,805 shares in the company, valued at $1,762,147.20. This represents a 9.50 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Bradford C. Connett sold 4,036 shares of the firm's stock in a transaction dated Wednesday, March 19th. The stock was sold at an average price of $71.15, for a total transaction of $287,161.40. Following the completion of the transaction, the chief executive officer now directly owns 62,688 shares in the company, valued at $4,460,251.20. This represents a 6.05 % decrease in their position. The disclosure for this sale can be found here. 1.14% of the stock is currently owned by company insiders.

Henry Schein Stock Down 2.0 %

Shares of HSIC traded down $1.31 during trading on Tuesday, reaching $64.30. The company's stock had a trading volume of 321,456 shares, compared to its average volume of 1,601,613. The company has a market cap of $7.98 billion, a price-to-earnings ratio of 26.46, a P/E/G ratio of 2.13 and a beta of 0.84. The company has a fifty day moving average of $71.58 and a two-hundred day moving average of $72.19. The company has a quick ratio of 0.82, a current ratio of 1.42 and a debt-to-equity ratio of 0.46. Henry Schein, Inc. has a twelve month low of $60.56 and a twelve month high of $82.49.

Henry Schein (NASDAQ:HSIC - Get Free Report) last released its earnings results on Tuesday, February 25th. The company reported $1.19 earnings per share for the quarter, missing the consensus estimate of $1.23 by ($0.04). Henry Schein had a return on equity of 12.90% and a net margin of 2.51%. The company had revenue of $3.19 billion during the quarter, compared to the consensus estimate of $3.25 billion. During the same period in the previous year, the firm posted $0.66 EPS. Henry Schein's revenue for the quarter was up 5.8% on a year-over-year basis. On average, sell-side analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current fiscal year.

Henry Schein Company Profile

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.